Yi Yang

发表

In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations

Shibo Jiang, L. Du, Yusen Zhou, 2015, Human vaccines & immunotherapeutics.

In Vivo Cyclophosphamide and IL-2 Treatment Impedes Self-Antigen-Induced Effector CD4 Cell Tolerization: Implications for Adoptive Immunotherapy1

A. Adler, Yi Yang, M. Long, 2004, The Journal of Immunology.

Generation of human MHC (HLA-A11/DR1) transgenic mice for vaccine evaluation

Yusen Zhou, Guangyu Zhao, Shihui Sun, 2016, Human vaccines & immunotherapeutics.

Enhanced Immune Response to Rabies Viruses by the Use of a Liposome Adjuvant in Vaccines.

Yi Yang, Yanchun Li, D. Zheng, 2017, Viral immunology.

Salmonella typhi Ty21a bacterial ghost vector augments HIV-1 gp140 DNA vaccine-induced peripheral and mucosal antibody responses via TLR4 pathway.

Shibo Jiang, L. Du, Yusen Zhou, 2012, Vaccine.

TFPR1 acts as an immune regulator and an efficient adjuvant for proteins and peptides by activating immune cells, primarily through TLR2.

Yusen Zhou, Yan Guo, Z. Kou, 2020, Vaccine.

A recombinant multi-epitope protein MEP1 elicits efficient long-term immune responses against HIV-1 infection

Yusen Zhou, Junfeng Li, Yan Guo, 2017, Human vaccines & immunotherapeutics.

A truncated fragment of Ov-ASP-1 consisting of the core pathogenesis-related-1 (PR-1) domain maintains adjuvanticity as the full-length protein

Shibo Jiang, L. Du, Yusen Zhou, 2015, Vaccine.

Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor.

R. Bravo, G. Warr, R. Ryseck, 1998, Journal of immunology.

A truncated fragment of Ov-ASP-1 consisting of the core pathogenesis-related-1 (PR-1) domain maintains adjuvanticity as the full-length protein

Shibo Jiang, L. Du, Yusen Zhou, 2015, Vaccine.